Drug Database
Back to search

United Kingdom· GB-APID-821811000001106

Cefradine 250mg capsules

A cefradine product containing cefradine, registered in United Kingdom by Kent Pharma (UK) Ltd. The same ATC class is registered in 2 of our 19 countries.

ATC J01DB09

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCefradine 250mg capsulesATCJ01DB09REGISTER NO.GB-APID-8218110000011…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cefradineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cefradine is registered in 2 of 19 countries.

Countries holding a registration under ATC J01DB09 (cefradine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 1 of them publish a price we can compare per daily dose
Search cefradine products by name

Cefradine · ATC J01DB09

2 / 19 countries

  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Cefradine
Manufacturer
Kent Pharma (UK) Ltd
Country
United Kingdom (GB)
ATC code
J01DB09
ATC class
Cefradine
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5015201005131

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for cefradine.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cefradine against other medicinesHow interaction checks work

Cefradine · interactions on record

20 records

  • 20 moderate

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01DB09

Cefradine, as other registers publish it.

All cefradine products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Portugal · Cefalmin, Cefradur

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f498abb4-cca5-415e-84bf-a04abb2ff5a1
GET /v1/drugs/f498abb4-cca5-415e-84bf-a04abb2ff5a1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "821811000001106",
  "desc": "Cefradine 250mg capsules (Kent Pharma (UK) Ltd)",
  "form": "Oral capsule",
  "vpid": "41944511000001103",
  "source": "dmd",
  "vtm_id": "775112000",
  "strength": "250 mg",
  "substance": "Cefradine",
  "ingredient": "Cefradine",
  "supplier_code": "2073701000001100"
}
API referenceMCP serverPlans

See everything about cefradine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console